These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10652960)

  • 1. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis.
    Yonemura K; Kimura M; Miyaji T; Hishida A
    Calcif Tissue Int; 2000 Feb; 66(2):123-8. PubMed ID: 10652960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol.
    Inoue T; Sugiyama T; Matsubara T; Kawai S; Furukawa S
    Endocr J; 2001 Feb; 48(1):11-8. PubMed ID: 11403096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine.
    Yonemura K; Fukasawa H; Fujigaki Y; Hishida A
    Am J Kidney Dis; 2004 Jan; 43(1):53-60. PubMed ID: 14712427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T; Satomura A; Hidaka M; Ohsawa I; Endo M; Ohi H
    Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.
    Shiraki M; Shiraki Y; Aoki C; Miura M
    J Bone Miner Res; 2000 Mar; 15(3):515-21. PubMed ID: 10750566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa.
    Iketani T; Kiriike N; Murray ; Stein B; Nagao K; Nagata T; Minamikawa N; Shidao A; Fukuhara H
    Psychiatry Res; 2003 Mar; 117(3):259-69. PubMed ID: 12686368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica.
    Pearce G; Ryan PF; Delmas PD; Tabensky DA; Seeman E
    Br J Rheumatol; 1998 Mar; 37(3):292-9. PubMed ID: 9566670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients.
    Sato Y; Honda Y; Kuno H; Oizumi K
    Bone; 1998 Sep; 23(3):291-6. PubMed ID: 9737352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.
    Shiraki M; Itabashi A
    J Bone Miner Metab; 2009; 27(3):333-40. PubMed ID: 19172219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver.
    Shiomi S; Nishiguchi S; Kubo S; Tamori A; Habu D; Takeda T; Ochi H
    Am J Gastroenterol; 2002 Apr; 97(4):978-81. PubMed ID: 12003435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
    Dubois EF; Röder E; Dekhuijzen PN; Zwinderman AE; Schweitzer DH
    Chest; 2002 May; 121(5):1456-63. PubMed ID: 12006428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone.
    Rianthavorn P; Pisutikul K; Deekajorndech T; Tepmongkol S; Suphapeetiporn K
    J Pediatr Endocrinol Metab; 2012; 25(3-4):307-12. PubMed ID: 22768661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S
    J Orthop Sci; 2000; 5(6):546-51. PubMed ID: 11180916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
    Tee SI; Yosipovitch G; Chan YC; Chua SH; Koh ET; Chan YH; Tan SS; Tsou IY; Tan SH
    Arch Dermatol; 2012 Mar; 148(3):307-14. PubMed ID: 22105813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of vitamin K2 administration in the patients with severely motor and intellectual disabilities: assessment of bone metabolic marker and bone mineral density].
    Tanaka Y; Shibata R
    No To Hattatsu; 2000 Nov; 32(6):491-6. PubMed ID: 11144162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of menatetrenone on prednisolone-induced bone loss in rats.
    Hara K; Akiyama Y; Ohkawa I; Tajima T
    Bone; 1993; 14(6):813-8. PubMed ID: 8155403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats.
    Hara K; Kobayashi M; Akiyama Y
    Bone; 2002 Nov; 31(5):575-81. PubMed ID: 12477571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K₂ therapy for postmenopausal osteoporosis.
    Iwamoto J
    Nutrients; 2014 May; 6(5):1971-80. PubMed ID: 24841104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.